CD8A and neoplasm: Further, Tregs can indirectly hamper CD8+ T cell activation by restraining expansion and immunogenicity of tumor-associated dendritic cells (DCs), leading to reduce IFNγ secretion and poor tumor control, as seen in an orthotopic pancreatic cancer model [97].